BSECompany Update6d ago · 30 Jul 2026, 04:15 pm
Allotment of 7,53,334 Convertible warrants in to Equity Shares on Preferential basis pursuant to Regulation 30 read with schedule III of SEBI LODR Regulation, 2015.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryFundraise
Venmax Drugs and Pharmaceuticals Ltd has allotted 7,53,334 equity shares to a warrant holder, Dinesh Muddu Kotian, at an issue price of Rs. 20 per share, increasing the company's paid-up capital to Rs. 14,48,39,290.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Allotment